Valspodar is an experimental cancer treatment and chemosensitizer derived from cyclosporine D, primarily studied for its ability to function as a selective P-glycoprotein inhibitor. By targeting this efflux… Read more
Valspodar is an experimental cancer treatment and chemosensitizer derived from cyclosporine D, primarily studied for its ability to function as a selective P-glycoprotein inhibitor. By targeting this efflux transporter, the compound aims to reverse multidrug resistance in tumor cells, thereby restoring the efficacy of chemotherapeutic agents. To support analytical investigations, this category includes high-quality reference standards of the active pharmaceutical ingredient, along with its associated impurities and metabolites. These materials are essential for pharmaceutical laboratories performing rigorous impurity profiling, method validation, and quality control. Furthermore, stable isotope labelled versions are available to serve as critical internal standards in bioanalytical assays, ensuring accurate quantification and reliable data during complex pharmacokinetic and clinical development studies.